{"altmetric_id":4442144,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["habdelkawy"],"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["201884256508122"],"posts_count":1}},"citation":{"doi":"10.4172\/2161-0959.1000200","first_seen_on":"2015-08-27T13:24:57+00:00","issns":["2161-0959"],"journal":"Journal of Nephrology & Therapeutics","last_mentioned_on":1441983601,"links":["http:\/\/www.omicsonline.org\/open-access\/urinary-biomarkers-igfbp7-and-timp2-for-aki-risk-stratification-are-we-there-yet-2161-0959-1000200.php?aid=50778"],"pdf_url":"http:\/\/www.omicsonline.org\/open-access\/urinary-biomarkers-igfbp7-and-timp2-for-aki-risk-stratification-are-we-there-yet-2161-0959-1000200.pdf","pubdate":"2015-05-04T00:00:00+00:00","publisher":"OMICS Group","title":"Urinary Biomarkers IGFBP-7 and TIMP-2 for AKI Risk Stratification: Are we there yet?","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/urinary-biomarkers-igfbp7-timp2-aki-risk-stratification-we"},"altmetric_score":{"score":1.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.25},"context_for_score":null},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Researcher":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":1,"Agricultural and Biological Sciences":1}}},"geo":{"twitter":{"KW":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/habdelkawy\/statuses\/636892091965018113","license":"gnip","citation_ids":[4442144],"posted_on":"2015-08-27T13:24:42+00:00","author":{"name":"hesham abdelkawy","image":"https:\/\/pbs.twimg.com\/profile_images\/416507183170191360\/PdnupNyi_normal.jpeg","description":"transplant nephrologist at Hamed al essa Organ transplant centre","id_on_source":"habdelkawy","tweeter_id":"99768461","geo":{"lt":"29.2733964","ln":"47.4979476","country":"KW"},"followers":20},"tweet_id":"636892091965018113"}],"facebook":[{"title":"Urinary Biomarkers IGFBP-7 and TIMP-2 for AKI Risk Stratification: Are we there yet? | Open...","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1142204382476100&id=201884256508122","license":"public","citation_ids":[4442144],"posted_on":"2015-09-11T15:00:01+00:00","summary":"#Urinary #Biomarkers IGFBP-7 and TIMP-2 for #AKI Risk Stratification: Are we there yet?\n-----------------------------------------------------\n\"Improving Global #Outcomes (KDIGO) recently published practice guidelines for identification and treatment of pat","author":{"name":"Nephrology & Therapeutics:CR","url":"https:\/\/www.facebook.com\/201884256508122","facebook_wall_name":"Nephrology & Therapeutics:CR","image":"https:\/\/graph.facebook.com\/201884256508122\/picture","id_on_source":"201884256508122"}}]}}